Angelos M. Stergiou
CIK 1724253 · President and CEO · last filed 2025-12-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$5.38M
Companies
2
Total Filings
16
Lifetime Open-Market Net
-$59.4K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SLS | President and CEO | 686,966 | $7.83 | $5.38M | -$59.4K | 15 | 2025-12-05 |
| SELLAS Life Sciences Group, Inc. (GALE) Delisted | President and CEO | 450,135 | — | — | $0 | 1 | 2017-12-29 |
Recent Filings · Page 2 of 2
16 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-03-08 | SLS | Grant (A) | +19,750 | $0 | EDGAR |
| 2020-03-16 | SLS | Grant (A) | +95,000 | $0 | EDGAR |
| 2019-03-18 | SLS | Grant (A) | — | $0 | EDGAR |
| 2019-01-03 | SLS | Sell (S) | −23,277 | -$29.2K | EDGAR |
| 2018-03-15 | SLS | Grant (A) | — | $0 | EDGAR |
| 2017-12-29 | SELLAS Life Sciences Group, Inc. (GALE) Delisted | Grant (A) | +450,135 | $0 | EDGAR |
Showing 11–16 of 16
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.